Permacol Paste in Perianal Crohn's Disease

NCT03776825 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-02-03

No results posted yet for this study

Summary

The purpose of this study is to collect data about the efficacy of Permacol Paste treatment in perianal Crohn's Disease.

Conditions

  • Crohn Disease
  • Perianal Fistula

Interventions

DEVICE

Permacol Paste

Permacol Paste Injection

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY
  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Antonino Spinelli, MD, PhD · Istituto Clinico Humanitas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-07
Primary Completion
2021-07-01
Completion
2021-10-01
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03776825 on ClinicalTrials.gov